- Home
- LWLG vs VSTM Comparison
LWLG vs VSTM Comparison
Compare LWLG & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- VSTM
- Stock Information
- Founded
- LWLG 1991
- VSTM 2010
- Country
- LWLG United States
- VSTM United States
- Employees
- LWLG N/A
- VSTM N/A
- Industry
- LWLG Containers/Packaging
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- LWLG Industrials
- VSTM Health Care
- Exchange
- LWLG Nasdaq
- VSTM Nasdaq
- Market Cap
- LWLG 560.5M
- VSTM 598.2M
- IPO Year
- LWLG N/A
- VSTM 2012
- Fundamental
- Price
- LWLG $4.59
- VSTM $8.99
- Analyst Decision
- LWLG
- VSTM Strong Buy
- Analyst Count
- LWLG 0
- VSTM 9
- Target Price
- LWLG N/A
- VSTM $13.38
- AVG Volume (30 Days)
- LWLG 2.1M
- VSTM 1.7M
- Earning Date
- LWLG 11-12-2025
- VSTM 11-05-2025
- Dividend Yield
- LWLG N/A
- VSTM N/A
- EPS Growth
- LWLG N/A
- VSTM N/A
- EPS
- LWLG N/A
- VSTM N/A
- Revenue
- LWLG $94,355.00
- VSTM $2,137,000.00
- Revenue This Year
- LWLG N/A
- VSTM $88.50
- Revenue Next Year
- LWLG N/A
- VSTM $398.66
- P/E Ratio
- LWLG N/A
- VSTM N/A
- Revenue Growth
- LWLG 4.52
- VSTM N/A
- 52 Week Low
- LWLG $0.79
- VSTM $2.54
- 52 Week High
- LWLG $5.22
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- LWLG 62.86
- VSTM 53.93
- Support Level
- LWLG $3.47
- VSTM $8.49
- Resistance Level
- LWLG $4.06
- VSTM $9.26
- Average True Range (ATR)
- LWLG 0.53
- VSTM 0.44
- MACD
- LWLG 0.04
- VSTM -0.12
- Stochastic Oscillator
- LWLG 65.19
- VSTM 52.30
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.